Literature DB >> 28503563

Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease.

Say-Yee Loo1, Wah-Kheong Chan1.   

Abstract

Entities:  

Year:  2017        PMID： 28503563      PMCID： PMC5411272          DOI： 10.21037/hbsn.2017.03.06

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

1.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

2.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

3.  Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

Authors:  Jérôme Boursier; Julien Vergniol; Anne Guillet; Jean-Baptiste Hiriart; Adrien Lannes; Brigitte Le Bail; Sophie Michalak; Faiza Chermak; Sandrine Bertrais; Juliette Foucher; Frédéric Oberti; Maude Charbonnier; Isabelle Fouchard-Hubert; Marie-Christine Rousselet; Paul Calès; Victor de Lédinghen
Journal:  J Hepatol       Date:  2016-05-02       Impact factor: 25.083

Review 4.  Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Larissa L Fujii; Mohammad Hassan Murad; Zhen Wang; Sumeet K Asrani; Richard L Ehman; Patrick S Kamath; Jayant A Talwalkar
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-15       Impact factor: 11.382

5.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

6.  Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.

Authors:  V W-S Wong; G L-H Wong; S W-C Tsang; A Y Hui; A W-H Chan; P C-L Choi; A M-L Chim; S Chu; F K-L Chan; J J-Y Sung; H L-Y Chan
Journal:  Aliment Pharmacol Ther       Date:  2008-11-17       Impact factor: 8.171

7.  Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.

Authors:  Donghee Kim; W Ray Kim; Hwa Jung Kim; Terry M Therneau
Journal:  Hepatology       Date:  2013-01-25       Impact factor: 17.425

8.  Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.

Authors:  Aynur Unalp-Arida; Constance E Ruhl
Journal:  Hepatology       Date:  2016-01-22       Impact factor: 17.425

9.  Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study.

Authors:  Mariana Lazo; Ruben Hernaez; Susanne Bonekamp; Ihab R Kamel; Frederick L Brancati; Eliseo Guallar; Jeanne M Clark
Journal:  BMJ       Date:  2011-11-18

10.  Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.

Authors:  Wah-Kheong Chan; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240
  10 in total
  1 in total

1.  Limited applicability of cathepsin D for the diagnosis and monitoring of non-alcoholic steatohepatitis.

Authors:  Sivesh K Kamarajah; Stanley Khoo; Wah-Kheong Chan; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva
Journal:  JGH Open       Date:  2019-04-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.